Ledger.Open graph →
SEC Form D · filed January 3, 2019

Phylos Bioscience, Inc

Offering
$20.0M
Sold
—
Exemption
Rule 506(b)
Industry
Other
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Nishan Karassik · Portland, ORExec · DirectorMowgli Holmes · Portland, ORExec · DirectorTimothy J. Gregory · Portland, ORDirectorScott J. Bowman · Portland, ORExecRalph J. Risch · Portland, ORExecDavid M. Mccoy · CHICAGO, ILExecNell M. Blatherwick · CHICAGO, ILExecDaniella Kranjac · Englewood Cliffs, NJDirectorMario M. Kranjac · Englewood Cliffs, NJExec · DirectorMichael D. Feinglass · CHICAGO, ILExec · DirectorStanton T. Marcum · Sanibel, FLExec · DirectorAndrea T. Johnson · Florence, KYExecVehano Joseph · Tampa, FLExecMatthew Morgan · Boston, MADirectorPeter Ballantyne · Houston, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗